Cargando…
A Highly Advanced Gastric Cancer Maintaining a Clinical Complete Response after Chemoradiotherapy Comprising S-1 and Cisplatin
We report a patient with highly advanced gastric carcinoma who was treated successfully with chemoradiotherapy (CRT) comprising S-1 and cisplatin. The patient was a 71-year-old male who was diagnosed with advanced gastric carcinoma by esophagogastroduodenoscopy (EGD) by medical examination. EGD demo...
Autores principales: | Yura, Masahiro, Takahashi, Tsunehiro, Fukuda, Kazumasa, Nakamura, Rieko, Wada, Norihito, Fukada, Junichi, Kawakubo, Hirofumi, Takeuchi, Hiroya, Shigematsu, Naoyuki, Kitagawa, Yuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180270/ https://www.ncbi.nlm.nih.gov/pubmed/30323733 http://dx.doi.org/10.1159/000492206 |
Ejemplares similares
-
Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-
por: Matsuda, Satoru, et al.
Publicado: (2014) -
Correction: phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis -KOGC04-
por: Matsuda, Satoru, et al.
Publicado: (2014) -
Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancer
por: NAKAMURA, RIEKO, et al.
Publicado: (2016) -
High‐risk group of upper and middle mediastinal lymph node metastasis in patients with esophagogastric junction carcinoma
por: Yura, Masahiro, et al.
Publicado: (2018) -
Experimental and clinicopathological analysis of HOXB9 in gastric cancer
por: Kato, Fumihiko, et al.
Publicado: (2019)